Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

EMEA issues positive recommendation for Schering-Plough's desloratadine

Oct. 13, 2000

New PDE4 inhibitors and methods of treating asthma

Oct. 10, 2000

Salus receives SBIR grant for cystic fibrosis research

Oct. 10, 2000

AxyS selects lead compound in asthma program

Oct. 10, 2000

R&D at Darwin Discovery leads to new group of PDE4/TNF inhibitors

Oct. 6, 2000

Phase III trial of Actimmune begins for treatment of idiopathic pulmonary fibrosis

Oct. 6, 2000

New cyclic amide compounds synthesized at Japanese lab act as selective M3 antagonists

Oct. 5, 2000

Cathepsin inhibitors claimed by AstraZeneca for use in COPD

Oct. 5, 2000

FDA approves breath-activated device with corticosteroid for asthma

Oct. 5, 2000

Novel IL-5 biosynthesis inhibitor R-146225 profiled at recent inflammation meeting

Oct. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...